Syros Pharmaceuticals (SYRS) Financials

$0.00

$-0.10 (-99.62%)

As on 11-Sep-2026 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

10.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	0.39	9.94	14.88	23.49	15.09	1.98
Cost of Revenue	1.27	2.25	2.97	--	--	--
Gross Profit	-0.88	7.68	11.91	23.49	15.09	1.98
Operating Expenses	111.30	30.77	38.81	122.91	97.39	79.72
Operating Profit (EBIT)	-111.52	-128.99	-135.87	-99.42	-82.30	-77.74
Other Income	--	--	45.35	--	0.05	2.30
Profit before Tax	-97.82	-164.57	-94.65	-86.56	-84.04	-75.44
Provision for Tax	10.85	2.08	-45.35	3.91	1.79	2.55
Profit after Tax (Net Income)	-97.82	-164.57	-94.65	-86.56	-84.04	-75.44
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-94.65	-86.56	-84.04	-75.44

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-11.12	16.66	127.74	85.22	90.55	79.18
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	67.73	114.83	85.97	66.21	94.07	47.28
Current Liabilities	28.39	36.68	30.78	31.51	28.62	23.52
Total Liabilities	113.39	168.17	244.49	182.94	213.25	149.98

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	21.06	23.19	33.09	46.35	34.69	35.47
Current Assets	63.93	144.98	211.39	136.59	178.56	114.51
Total Assets	113.39	168.17	244.49	182.94	213.25	149.98
Total Debt*	60.23	62.08	63.57	65.19	66.21	25.92
Net Current Assets	35.54	108.30	180.61	105.08	149.93	91.00

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-109.71	-123.07	-99.54	-57.36	-60.25
Cash Flow from Investing Activities	--	37.34	67.19	-52.65	46.66	-11.73
Cash from Financing Activities	--	43.46	131.05	70.51	142.95	65.99
Net Cash Inflow / Outflow	--	--	75.17	--	132.25	-6.00

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-3.03	-5.57	-3.41	-13.76	-13.69	-17.17
Cash EPS ($)	--	-5.49	-3.30	-13.28	-13.20	-16.55
Adjusted Book Value ($)	--	0.56	4.60	13.54	14.75	18.03
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.71	-4.43	-15.82	-9.35	-13.72
Free Cash Flow per Share ($)	--	-3.72	-4.48	-16.02	-9.89	-16.59

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-121.89	-55.40	-56.36	-64.18	-82.12
ROE (%)	--	-227.94	-88.90	-98.49	-99.02	-95.63
ROA (%)	-67.56	-79.76	-44.29	-43.70	-46.27	-58.77
EBIT Margin (%)	-23,959.84	-1,604.74	-608.33	-351.89	-544.93	-3,806.16
Net Margin (%)	-25,340.67	-1,656.34	-157.15	-368.52	-554.93	-1,760.51
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-90.54	-0.33	-0.37	0.56	6.62	-0.03
EBIT Growth (%)	7.55	-76.15	-9.52	-0.49	-9.02	-21.13
Net Profit Growth (%)	-53.44	-73.87	-9.35	-3.00	-11.40	-21.13
EPS Growth (%)	-33.21	-0.63	0.75	0.00	0.20	0.07
Book Value Growth (%)	-121.80	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-1.40	-1.05	-0.24	-0.79	-0.40
Price / Book Value	10.65	13.81	0.78	0.24	0.74	0.38
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.41	-0.97	0.45	0.56	0.52	0.48
Close Price ($)	2.15	7.79	3.59	32.60	108.50	69.10
High Price ($)	8.17	8.05	38.50	154.90	156.50	119.30
Low Price ($)	1.43	2.09	3.02	32.30	42.60	44.50
Market Cap ($ Cr)	0.01	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	-3.69	3.73	0.50	0.76	0.73	0.33
Short term debt to equity ratio	-0.23	0.54	0.02	0.02	0.02	0.02
Current Ratio	2.25	3.95	6.87	4.33	6.24	4.87
Quick Ratio	2.25	--	6.87	--	6.24	4.86
Interest Coverage	-17.35	-31.10	-21.90	-21.15	-45.90	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	11.38	12.68	15.44	1,017.05
Asset Turnover	0.00	0.05	0.07	0.12	0.08	0.02
Receivable days	--	62.27	57.35	41.29	272.12	3,714.79
Inventory Days	--	0.00	0.00	--	--	--
Payable days	--	1,456.05	621.86	--	--	--
Cash Conversion Cycle	--	-1,393.78	-564.51	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.